Valuation (66%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 20.83 | N/A |
| PEG Ratio (TTM) | -1.22 | N/A |
| P/S Ratio (TTM) | 1.14 | N/A |
| P/B Ratio (TTM) | 1.18 | N/A |
| P/FCF Ratio (TTM) | 18.28 | N/A |
| Price to 5YR AVG Earnings Ratio | 19.43 | N/A |
| Price to 5YR AVG FCF Ratio | 18.23 | N/A |
Profitability (30%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 3.82% | N/A |
| ROE (TTM) | 5.85% | N/A |
| Net Profit Margin (TTM) | 5.46% | N/A |
| ROIC 5YR AVG | 5.92% | N/A |
Growth (57%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 100.04% | -5.99% | 76.30% |
| Revenue | 4.25% | -2.07% | 2.87% |
| Net Income | 81.98% | -4.39% | 72.43% |
| Cash Flow | 61.60% | -7.83% | 25.83% |
Health (68%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 2.17 | N/A |
| Quick Ratio (TTM) | 1.84 | N/A |
| D/E Ratio (TTM) | 0.02 | N/A |
| Interest Coverage (TTM) | N/A | N/A |
| Piotroski F-Score | 7 | N/A |
| Altman Z-Score | 0.61 | N/A |
| LTL to 5YR AVG FCF | 0.27 | N/A |
| Shares Outstanding Growth 5YR AVG | 0.63% | N/A |